ZOLGENSMA

Welcome to the Brand page for “ZOLGENSMA”, which is offered here for The mark consists of a small section of a dna helix above and to the left of the letter z in the word zolgensma, which is in lowercase; the wording zolgensma and the left side and middle bars of the helix are dark magenta and the right side of the helix are green.;pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression;the color(s) dark magenta and green is/are claimed as a feature of the mark.;the wording zolgensma has no meaning in a foreign language.;medical services, providing educational information regarding prescription drugs and disease treatment;research and development of technology in the field of disease treatment;.

Its status is currently believed to be active. Its class is unavailable. “ZOLGENSMA” is believed to be currently owned by “NOVARTIS AG”.

Owner:
NOVARTIS AG
Owner Details
Description:
The mark consists of a small section of a DNA helix above and to the left of the letter Z in the word ZOLGENSMA, which is in lowercase; the wording ZOLGENSMA and the left side and middle bars of the helix are dark magenta and the right side of the helix are green.;Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression;The color(s) dark magenta and green is/are claimed as a feature of the mark.;The wording ZOLGENSMA has no meaning in a foreign language.;Medical services, providing educational information regarding prescription drugs and disease treatment;Research and development of technology in the field of disease treatment;
Categories: